FDA 483 - Hendrick Regional Blood Center - June 27, 2025

An FDA inspection of Hendrick Regional Blood Center in Abilene, TX, revealed multiple deficiencies in blood collection and processing. Observations included improper disposal of obsolete labels, failure to verify donor identity, and incorrect medical history assessments. Additionally, the firm was cited for inadequate venipuncture site preparation and improper quality checks for screening equipment, indicating a need for improved adherence to procedures and manufacturer guidelines.